MARGARIC ACID DECREASES PIEZO2-MEDIATED PAIN
Canada
3167629
Filed on 2022-08-10
3167629
Filed on 2022-08-10
MARGARIC ACID DECREASES PIEZO2-MEDIATED MEDIATED PAIN
Japan
2022-548411
Filed on 2021-02-12
2022-548411
Filed on 2021-02-12
MARGARIC ACID DECREASES PIEZO2-MEDIATED MEDIATED PAIN
Patent Cooperation Treaty
PCT/US2021/017780
Filed on 2021-02-12
PCT/US2021/017780
Filed on 2021-02-12
Treatment of Metabolic Syndrome and Insulin Resistance with Citrus Flavones
US Application 13/813,072
Filed on 2013-01-29
Filed on 2013-01-29
Treatment of Metabolic Syndrome and Insulin Resistance with Citrus Flavanones
India
1665/DELNP/2013
Filed on 2011-07-29
1665/DELNP/2013
Filed on 2011-07-29
Treatment of Metabolic Syndrome and Insulin Resistance with Citrus Flavanones
European Patent
11813251.3
Filed on 2011-07-29
11813251.3
Filed on 2011-07-29
Treatment of Metabolic Syndrome and Insulin Resistance with Citrus Flavanones
Canada
2807006
Filed on 2011-07-29
2807006
Filed on 2011-07-29
Treatment of Metabolic Syndrome and Insulin Resistance with Citrus Flavanones (AU)
Australia
2011282511
Filed on 2011-07-29
2011282511
Filed on 2011-07-29
Treatment of Metabolic Syndrome and Insulin Resistance with Citrus Flavanones
Patent Cooperation Treaty
PCT/US2011/045898
Filed on 2011-07-29
PCT/US2011/045898
Filed on 2011-07-29
LOW LEVEL EXPOSURE TO EXTRACT OF NEUROTOXIN FOR PROTECTION FROM BRAIN INJURY
US Application 09/271,009
Filed on 1999-03-17
Filed on 1999-03-17